Faced with an increasing CLABSI rate on their oncology unit, nurse leaders at this rural Northwest hospital surveyed their staff to identify the changes they needed to make. Implementing those changes resulted in a dramatic improvement in patient care outcomes.
Researchers have determined that, relative to differentiated tumor progeny or normal neuronal cells, ZIKV preferentially infects and kills GSCs.
HIV infection may not have a contributory effect on the incidence of invasive cervical cancer (ICC) in women as they age.
Patients with cancer experience several risk factors for developing Clostridium difficile, and results of a recent study have shown that infection with C difficile is increasing in frequency and negatively affects clinical and care outcomes.
A new report from ACS describes trends in liver cancer and the factors influencing the ongoing increase in incidence, particularly higher rates of HCV infection, obesity, and type 2 diabetes.
Approximately 40% of ITP cases are caused by gram-negative H pylori infection; therefore, researchers sought to determine the effectiveness of infection eradication on platelet count in these patients.
Cancer rates among people with HIV, particularly AIDS-defining cancers, are projected to decrease by 2030.
A team of researchers discovered a method for early detection of aspergillosis, a potentially deadly fungal infection, in patients whose disease or treatment involves immune system suppression.
New research from infection control specialists found that UV robots helped reduce transmission rates of Clostridium difficile. The intervention also saved approximately $150,000 in annual direct medical costs.
The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma.
A patient's microbial diversity, even before they start cancer treatment, can be linked to risk of infection during induction chemotherapy.
This review discusses common risk factors, treatment, and preventive measures for aspergillosis in hematopoietic stem transplantation recipients.
A newly developed antifungal has proved as effective against invasive mold disease in cancer patients as the standardly used drug, voriconazole, with fewer side effects.
People with late-stage cancer at the back of the mouth or throat that recurs after chemotherapy and radiation treatment are twice as likely to be alive 2 years later if their cancer is caused by the human papillomavirus.
A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.
Certain types of papillomavirus might actually prevent cervical cancer, according to a new study. More than 100 different types of HPV are known, and approximately 14 "high-risk" HPV types are known to cause cervical cancer.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Encorafenib, Binimetinib Combination Receives FDA Approval for Mutation-Positive Melanoma
- Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|